Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 482146, 8 pages
http://dx.doi.org/10.1155/2015/482146
Review Article

Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis

1Department of Hematology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China
2Center of Clinical Laboratory Science, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China
3Department of Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, China
4Department of Pathology, Medical School, Southeast University, Nanjing 210009, China

Received 13 January 2015; Accepted 14 April 2015

Academic Editor: Andreas Pich

Copyright © 2015 Fei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Ling, M. Fabbri, and G. A. Calin, “MicroRNAs and other non-coding RNAs as targets for anticancer drug development,” Nature Reviews Drug Discovery, vol. 12, no. 11, pp. 847–865, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Bouyssou, S. Manier, D. Huynh, S. Issa, A. M. Roccaro, and I. M. Ghobrial, “Regulation of microRNAs in cancer metastasis,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1845, no. 2, pp. 255–265, 2014. View at Publisher · View at Google Scholar
  4. M. Guz, A. Rivero-Müller, E. Okoń et al., “MicroRNAs-role in lung cancer,” Disease Markers, vol. 2014, Article ID 218169, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hayes, P. P. Peruzzi, and S. Lawler, “MicroRNAs in cancer: biomarkers, functions and therapy,” Trends in Molecular Medicine, vol. 20, no. 8, pp. 460–469, 2014. View at Publisher · View at Google Scholar
  6. M. Wang, Y. Wang, W. Zang et al., “Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells,” Tumor Biology, vol. 35, no. 1, pp. 39–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Pignot, G. Cizeron-Clairac, S. Vacher et al., “MicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer,” International Journal of Cancer, vol. 132, no. 11, pp. 2479–2491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Cekaite, J. K. Rantala, J. Bruun et al., “MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer,” Neoplasia, vol. 14, no. 9, pp. 868–879, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Liu, Y. Wang, X. Li et al., “Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1,” Tumor Biology, vol. 34, no. 3, pp. 1713–1722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W.-Q. Kong, R. Bai, T. Liu et al., “MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma,” The FEBS Journal, vol. 279, no. 7, pp. 1252–1260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. F. G. Rodríguez-González, A. M. Sieuwerts, M. Smid et al., “MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer,” Breast Cancer Research and Treatment, vol. 127, no. 1, pp. 43–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, article 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Wang, M. H. Yang, X. Y. Wang, J. Lin, and Y. Q. Ding, “Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3498–3503, 2014. View at Google Scholar
  15. H. Stenvold, T. Donnem, S. Andersen, S. Al-Saad, L.-T. Busund, and R. M. Bremnes, “Stage and tissue-specific prognostic impact of miR-182 in NSCLC,” BMC Cancer, vol. 14, no. 1, article 138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Rapti, C. K. Kontos, I. N. Papadopoulos, and A. Scorilas, “Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 8, pp. 1217–1227, 2014. View at Google Scholar
  17. C. Li, X. Du, S. Tai et al., “GPC1 regulated by miR-96-5p, rather than miR-182-5p, in inhibition of pancreatic carcinoma cell proliferation,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6314–6327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Lei, J. Tang, X. Zhuang et al., “Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis,” Oncogene, vol. 33, no. 10, pp. 1287–1296, 2014. View at Publisher · View at Google Scholar
  19. Q. Chen, L. Yang, Y. Xiao, J. Zhu, and Z. Li, “Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer,” Medical Oncology, vol. 31, no. 11, article 225, 2014. View at Publisher · View at Google Scholar
  20. I. Casanova-Salas, J. Rubio-Briones, A. Calatrava et al., “Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy,” The Journal of Urology, vol. 192, no. 1, pp. 252–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Liu, L. Du, Z. Wen et al., “Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value,” International Journal of Colorectal Disease, vol. 28, no. 5, pp. 697–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Kunder, R. Jalali, E. Sridhar et al., “Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas,” Neuro-Oncology, vol. 15, no. 12, pp. 1644–1651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Hirata, K. Ueno, V. Shahryari et al., “MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer,” PLoS ONE, vol. 8, no. 1, Article ID e55502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wang, J. Li, J. Shen, C. Wang, L. Yang, and X. Zhang, “MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma,” BMC Cancer, vol. 12, article 227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. D. McMillen, M. M. Aponte, Z. Liu et al., “Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma,” Modern Pathology, vol. 25, no. 12, pp. 1644–1653, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Hirata, K. Ueno, V. Shahryari et al., “Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer,” PLoS ONE, vol. 7, no. 11, Article ID e51056, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Zhu, X. Liu, J. He, D. Chen, Y. Hunag, and Y. K. Zhang, “Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study,” BMC Cancer, vol. 11, article 393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Schaefer, M. Jung, H.-J. Mollenkopf et al., “Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma,” International Journal of Cancer, vol. 126, no. 5, pp. 1166–1176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Jiang, P. Mao, L. Song et al., “miR-182 as a prognostic marker for glioma progression and patient survival,” The American Journal of Pathology, vol. 177, no. 1, pp. 29–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Zhong, L. Chen, M. Lv, T. Ma, X. Zhang, and J. Zhao, “Nonoccupational physical activity and risk of ovarian cancer: a meta-analysis,” Tumor Biology, vol. 35, no. 11, pp. 11065–11073, 2014. View at Publisher · View at Google Scholar
  31. S. Wang, H. Li, J. Wang, D. Wang, A. Yao, and Q. Li, “Prognostic and biological significance of microRNA-127 expression in human breast cancer,” Disease Markers, vol. 2014, Article ID 401986, 12 pages, 2014. View at Publisher · View at Google Scholar
  32. Y. Shao, Y. Geng, W. Gu, J. Huang, Z. Ning, and H. Pei, “Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis,” Disease Markers, vol. 2014, Article ID 626185, 10 pages, 2014. View at Publisher · View at Google Scholar
  33. M. Li, X. Ma, M. Li et al., “Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis,” Disease Markers, vol. 2014, Article ID 106197, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. T. S. Lee, H. W. Jeon, Y. B. Kim, Y. A. Kim, M. A. Kim, and S. B. Kang, “Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues,” PLoS ONE, vol. 8, no. 12, Article ID e81421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Medimegh, I. Omrane, M. Privat et al., “MicroRNAs expression in triple negative vs non triple negative breast cancer in tunisia: interaction with clinical outcome,” PLoS ONE, vol. 9, no. 11, Article ID e111877, 2014. View at Publisher · View at Google Scholar
  36. M. Kunz, “MicroRNAs in melanoma biology,” Advances in Experimental Medicine and Biology, vol. 774, pp. 103–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Sachdeva, J. K. Mito, C. L. Lee et al., “MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes,” The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4305–4319, 2014. View at Publisher · View at Google Scholar
  38. W.-B. Yang, P.-H. Chen, T.-I. Hsu et al., “Sp1-mediated microRNA-182 expression regulates lung cancer progression,” Oncotarget, vol. 5, no. 3, pp. 740–753, 2014. View at Google Scholar · View at Scopus